BMS-986165
IM011-023
Phase 2 small_molecule terminated
Quick answer
BMS-986165 for Granulomatous Colitis is a Phase 2 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Granulomatous Colitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated